|Dr. Stephen T. Chen||Chairman, CEO, Pres, CFO & COO||349.63k||N/A||1950|
|Mr. Bernard Cohen||VP of Admin.||83.4k||N/A||1953|
|Mr. John Junyong Lee Esq.||Corp. Legal Counsel||N/A||N/A||N/A|
Amarillo Biosciences, Inc., a healthcare company, discovers and develops biologics for the treatment of human and animal diseases. The company owns or licenses six issued patents related to the low-dose oral delivery of interferon; and one patent associated with a dietary supplement, Maxisal. It focuses on research for the treatment of human disease indications primarily influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha. Amarillo Biosciences, Inc. was founded in 1984 and is based in Amarillo, Texas.
Amarillo Biosciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.